JMVNX
Price
$17.48
Change
-$0.06 (-0.34%)
Updated
Jul 31 closing price
Net Assets
1.24B
JVMRX
Price
$31.40
Change
+$0.02 (+0.06%)
Updated
Jul 31 closing price
Net Assets
23.61B
Interact to see
Advertisement

JMVNX vs JVMRX

JMVNX vs JVMRX Comparison Chart in %
View a ticker or compare two or three
VS
JMVNX vs. JVMRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a Hold and JVMRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.6B vs. JMVNX (1.24B). JMVNX pays higher dividends than JVMRX: JMVNX (1.15) vs JVMRX (0.75). JMVNX was incepted earlier than JVMRX: JMVNX (18 years) vs JVMRX (15 years). JMVNX (0.96) is less costly to investors than JVMRX (0.75). JMVNX is a more actively managed with annual turnover of: 56.00 vs. JVMRX (48.00). JMVNX has a lower initial minimum investment than JVMRX: JMVNX (0) vs JVMRX (1000000). JMVNX annual gain was more profitable for investors over the last year : 17.10 vs. JVMRX (8.86). JVMRX return over 5 years is better than : 16.31 vs. JMVNX (-4.16).
JMVNXJVMRXJMVNX / JVMRX
Total Expense Ratio0.950.74128%
Annual Report Gross Expense Ratio0.960.75128%
Fund Existence18 years15 years-
Gain YTD20.13714.348140%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B23.6B5%
Annual Yield % from dividends1.150.75153%
Returns for 1 year17.108.86193%
Returns for 3 years7.3419.2938%
Returns for 5 years-4.1616.31-26%
Returns for 10 years25.0663.7339%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCECX19.150.41
+2.19%
ClearBridge Emerging Markets C
FPUKX27.810.13
+0.47%
Fidelity Puritan K
FEXRX15.260.07
+0.46%
First Eagle U.S. SMID Cap Opportunity R6
GSMCX41.06-0.04
-0.10%
Goldman Sachs Mid Cap Value Instl
FSGAX47.10-0.13
-0.28%
Franklin Small-Mid Cap Growth Adv